GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (OTCPK:MBGPF) » Definitions » Cyclically Adjusted FCF per Share

MBGPF (Moberg Pharma AB) Cyclically Adjusted FCF per Share : $-4.15 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Moberg Pharma AB Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Moberg Pharma AB's adjusted free cash flow per share for the three months ended in Dec. 2024 was $-0.029. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-4.15 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Moberg Pharma AB was -7.20% per year. The lowest was -7.60% per year. And the median was -7.40% per year.

As of today (2025-04-13), Moberg Pharma AB's current stock price is $0.7098. Moberg Pharma AB's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2024 was $-4.15. Moberg Pharma AB's Cyclically Adjusted Price-to-FCF of today is .


Moberg Pharma AB Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Moberg Pharma AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moberg Pharma AB Cyclically Adjusted FCF per Share Chart

Moberg Pharma AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.02 - - - -4.15

Moberg Pharma AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.49 -4.68 -4.93 -4.15

Competitive Comparison of Moberg Pharma AB's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moberg Pharma AB's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's Cyclically Adjusted Price-to-FCF falls into.


;
;

Moberg Pharma AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Moberg Pharma AB's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.029/132.9872*132.9872
=-0.029

Current CPI (Dec. 2024) = 132.9872.

Moberg Pharma AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.247 100.225 0.328
201503 -0.334 99.950 -0.444
201506 -0.669 99.995 -0.890
201509 0.459 100.228 0.609
201512 -0.070 100.276 -0.093
201603 -0.362 100.751 -0.478
201606 0.063 101.019 0.083
201609 -16.443 101.138 -21.621
201612 -16.571 102.022 -21.601
201703 -0.427 102.022 -0.557
201706 -1.418 102.752 -1.835
201709 2.138 103.279 2.753
201712 1.137 103.793 1.457
201803 -0.705 103.962 -0.902
201806 0.715 104.875 0.907
201809 -0.086 105.679 -0.108
201812 -0.319 105.912 -0.401
201903 0.226 105.886 0.284
201906 -2.946 106.742 -3.670
201909 -1.500 107.214 -1.861
202003 -0.435 106.563 -0.543
202006 -0.754 107.498 -0.933
202009 -0.566 107.635 -0.699
202012 -0.623 108.296 -0.765
202103 -0.348 108.360 -0.427
202106 -0.154 108.928 -0.188
202109 -0.207 110.338 -0.249
202112 -0.115 112.486 -0.136
202203 -0.440 114.825 -0.510
202206 -0.227 118.384 -0.255
202209 -0.154 122.296 -0.167
202212 -0.166 126.365 -0.175
202303 -0.376 127.042 -0.394
202306 -0.278 129.407 -0.286
202309 -0.118 130.224 -0.121
202312 -0.083 131.912 -0.084
202403 -0.044 132.205 -0.044
202406 -0.082 132.716 -0.082
202409 -0.054 132.304 -0.054
202412 -0.029 132.987 -0.029

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Moberg Pharma AB  (OTCPK:MBGPF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Moberg Pharma AB Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Moberg Pharma AB Business Description

Industry
Traded in Other Exchanges
Address
Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51
Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Its geographic areas are Europe, the Americas, and Rest of the world.